Trendline support was broken. Now the price is making a pullback to the broken trend. Risk trade to sell closer to trendline. Less risky to sell on break of the first trigger. Target 38.
After a huge run, Incyte Pharmaceuticals is tired and this flag suggest more downside to come.
Lupin seems to be in a leading diagonal after a big flat correction with C=1.618*A. Hence it could continue to newer highs. Any move below the wave C low would negate the count.
On hourly chart, the price action breaks out from a consolidation that shall move prices to next resistance level of 865 levels. Target 865 Stoploss: 830
i think this is good for long tern today its give breakout
ONTX Triple Bottom with increasing volume. I'm looking to be moderately conservative on this buy; the 38.2% Fibonacci level will act as a nice price target for this bullish play. Viewing this chart, one can see that ONTX has been unable to sustain its gains above the 50% fibline, so you may be able to sell at that point, but as a low float stock anything can...
trend line breakout and RSI divergence and take Fibonacci retracement 23% support it can go upto 778 1st tgt
Wockpharma seems to have broken out of it's channel to the downside. Hence a move towards the LTL is possible. IF there is an upmove (and a reversal) from the channel LTL (as shown by the arrows) then it'd be a great short. In general, up moves could be shorting opportunities. An up move and a closing inside the channel could be a spoiler for this setup.
Mangalum Drugs seems to be ending it's downtrend. A close above the UTL could signal the start of the new impulse. It's likely that this impulse would lead it to new highs.
The wave 2 correction in Mangalam Drugs seems to have become a bit complex. Now it appears to be at a structural support. Also there is 61% Fib support. So it's likely that the up move could start. Any move below wave 1 low would negate this setup.
Project Manager. OCKT:EERB EERB 7/08/2016 vlp.eppershh@gmail.com Growth Rate Charts:PIP: POPS Equity Business Ratio 7+3=equity return of business;CALL,PUT.BP.IN.ATM.:(ABC)+1 Sell price to bank. Comprehensible. Comprehensible input
Lupin seems to have broken out of it's consolidation after tracing an Elongated Flat correction. In the long term, it seems to be a good long.
Longer time frame. Decent risk reward ratio of 3x. LUPIN seems to be settling above 200DMA and the next resistance is at 1878. It should reach there in a month or so.
As per the observations, it has made a breakout from downward trending line on daily charts and also building a bull flag pattern. I would be expecting a breakout from current levels to reach target of 1850 levels. Target 1: 1760 Target 2: 1800 Target 3: 1850 Stoploss: 1720
Auro Pharma seems to be starting a healthly uptrend. It's under consolidation now. Going long upon the upper trendline break could be a good idea. The safest entry would be on the break of the topmost trendline.